Skip to main content
. 2020 Nov 16;18(1):412–429. doi: 10.1007/s13311-020-00958-8

Fig. 5.

Fig. 5

Anti-HuR ASO treatment inhibition of BBB permeability in the brain and spinal cord of EAE mice. Representative pictures of liver, kidney, spleen (a), brain, and spinal cords (b) from naïve, CTRL, EAE, and anti-HuR ASO-treated EAE mice are displayed. Blue color indicates extravasated Evans blue dye from blood vessels. The amount of extravasated Evans blue dye was quantified in the brain (c) and lumbar spinal cord (d), at 30 days after immunization (n = 7 per group). A significant increase of extravasated Evans blue dye was detected in the brain and spinal cord of EAE that was attenuated by anti-HuR ASO. CTRL, dODN-treated nonimmunized mice; EAE, dODN-treated EAE mice; EAE + ASO, anti-HuR ASO-treated EAE mice. Error bars represent the standard error of the mean. *p < 0.05, **p < 0.01 versus CTRL; °p < 0.05, °°p < 0.01 versus EAE (ANOVA)